Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.
-Company continues to advance PGN-EDO51 in CONNECT1-EDO51, with the 10 mg/kg cohort now fully enrolled- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
– FREEDOM-DM1 data from 5 and 10 mg/kg cohorts in patients with DM1 expected in the first quarter of 2025 – – Study designs of CONNECT program optimized based on encouraging results from early...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.9127 | -16.8310988991 | 5.4227 | 5.72 | 2.9 | 460713 | 4.7138528 | CS |
| 4 | 0.4987 | 12.4323785307 | 4.0113 | 6.85 | 2.9 | 221253 | 5.06499377 | CS |
| 12 | -4.36 | -49.1544532131 | 8.87 | 9.935 | 2.9 | 143330 | 5.83116421 | CS |
| 26 | -12.49 | -73.4705882353 | 17 | 19.298 | 2.9 | 155939 | 9.46590959 | CS |
| 52 | -2.11 | -31.8731117825 | 6.62 | 19.298 | 2.9 | 127445 | 10.8028681 | CS |
| 156 | -11.09 | -71.0897435897 | 15.6 | 20 | 2.9 | 112820 | 10.85310861 | CS |
| 260 | -11.09 | -71.0897435897 | 15.6 | 20 | 2.9 | 112820 | 10.85310861 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
